serw-MX  [xml]  
 


    
 Categorias DeCS

C23 Pathological Conditions, Signs and Symptoms .
C23.550 Pathologic Processes .
C23.550.291 Disease Attributes .
C23.550.291.500 Chronic Disease .
C23.550.291.500.500 Multiple Chronic Conditions .
D03 Heterocyclic Compounds .
D03.132 Alkaloids .
D03.132.577 Opiate Alkaloids .
D03.132.577.249 Morphinans .
D03.132.577.249.706 Naloxone .
D03.132.577.249.706.550 Naltrexone .
D03.605 Heterocyclic Compounds, Bridged-Ring .
D03.605.497 Morphinans .
D03.605.497.750 Naloxone .
D03.605.497.750.550 Naltrexone .
D03.633 Heterocyclic Compounds, Fused-Ring .
D03.633.400 Heterocyclic Compounds, 4 or More Rings .
D03.633.400.686 Morphinans .
D03.633.400.686.750 Naloxone .
D03.633.400.686.750.550 Naltrexone .
D04 Polycyclic Compounds .
D04.615 Polycyclic Aromatic Hydrocarbons .
D04.615.723 Phenanthrenes .
D04.615.723.795 Morphinans .
D04.615.723.795.706 Naloxone .
D04.615.723.795.706.550 Naltrexone .
K01 Humanities .
K01.752 Philosophy .
K01.752.566 Morals .
K01.752.566.479 Ethics .
K01.752.566.479.117 Ethical Review .
N05 Health Care Quality, Access, and Evaluation .
N05.350 Ethics .
N05.350.250 Ethical Review .
V02 Publication Formats .
V02.600 Journal Article .
V02.600.500 Review .
V02.912 Review .
 
 Termos
 Sinônimos e Históricos
Documentos
LILACS e MDL
 
Review .
Review Literature .
Review of Reported Cases .
Review, Academic .
Review, Multicase .
Review, Systematic .
Review, Academic .
Review, Multicase .
Review, Systematic .
Review, Tutorial .
Review of Reported Cases .
Review Literature .
Review [Publication Type] .
Review of Reported Cases [Publication Type] .
Review, Multicase [Publication Type] .
Review, Tutorial [Publication Type] .
Review Literature [Publication Type] .
Literature Review [Publication Type] .
Review, Academic [Publication Type] .
Review, Systematic [Publication Type] .
1.00
 
Multiple Chronic Conditions .
Multi .
Multiple Chronic Diseases .
Multiple Chronic Health Conditions .
Multiple Chronic Illnesses .
Multiple Chronic Medical Conditions .
Multiple Morbidity .
Chronic Conditions, Multiple .
Chronic Disease, Multiple .
Chronic Diseases, Multiple .
Chronic Illnesses, Multiple .
Morbidity, Multiple .
Multiple Chronic Disease .
Multus .
0.57
 
Ethical Review .
Review, Ethical .
0.52
 
Naltrexone .
Antaxone .
Celupan .
EN-1639A .
Nalorex .
Naltrexone Hydrochloride .
Nemexin .
ReVia .
Trexan .
EN 1639A .
EN1639A .
Hydrochloride, Naltrexone .
0.51